Patents by Inventor Stan LOUIE

Stan LOUIE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190101539
    Abstract: A method of identifying subjects with colorectal cancer (CRC) is provided. The method includes obtaining a sample from a subject, determining a level of one or more folate one carbon metabolism (FOCM) metabolites in the sample of the subject, and comparing the level of the FOCM metabolites in the sample of the subject to a level in a non CRC control.
    Type: Application
    Filed: January 22, 2016
    Publication date: April 4, 2019
    Applicant: UNIVERSITY OF SOUTHERN CALIFORNIA
    Inventors: David CONTI, Fredrick SCHUMACHER, Stan LOUIE, Isaac ASANTE
  • Patent number: 9844578
    Abstract: Disclosed herein are methods for treating eye injuries by administering one or more angiotensin peptides to a subject with an eye injury.
    Type: Grant
    Filed: April 30, 2014
    Date of Patent: December 19, 2017
    Assignee: University of Southern California
    Inventors: Kathleen E. Rodgers, Gere S. Dizerega, Mark Humayun, Stan Louie, Walid Fouad Ahmed Abdallah
  • Patent number: 9623084
    Abstract: The present invention provides methods for treating or limiting development of multiple sclerosis by administering angiotensin peptides to a subject with multiple sclerosis or at risk of developing multiple sclerosis.
    Type: Grant
    Filed: March 13, 2014
    Date of Patent: April 18, 2017
    Assignee: University of Southern California
    Inventors: Kathleen E. Rodgers, Gere S. DiZerega, Brett Lund, Eve Kelland, Stan Louie
  • Publication number: 20160051622
    Abstract: Disclosed herein are methods for treating eye injuries by administering one or more angiotensin peptides to a subject with an eye injury.
    Type: Application
    Filed: April 30, 2014
    Publication date: February 25, 2016
    Inventors: Kathleen E. RODGERS, Gere S. DIZEREGA, Mark HUMAYUN, Stan LOUIE, Walid Fouad Ahmed ABDALLAH
  • Publication number: 20160000880
    Abstract: The present invention provides methods for treating or limiting development of multiple sclerosis by administering angiotensin peptides to a subject with multiple sclerosis or at risk of developing multiple sclerosis.
    Type: Application
    Filed: March 13, 2014
    Publication date: January 7, 2016
    Applicant: University of Southern California
    Inventors: Kathleen E. RODGERS, Gere S. DIZEREGA, Brett LUND, Eve KELLAND, Stan LOUIE